The influence of statin treatment on the inflammatory biomarkers YKL-40 and HsCRP in patients with stable coronary artery disease

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

The influence of statin treatment on the inflammatory biomarkers YKL-40 and HsCRP in patients with stable coronary artery disease. / Mygind, Naja Dam; Harutyunyan, Marina J; Mathiasen, Anders Bruun; Ripa, Rasmus Sejersten; Thune, Jens Jacob; Gøtze, Jens Peter; Johansen, Julia S; Kastrup, Jens; The CLARICOR Trial Group.

I: Inflammation Research, Bind 60, Nr. 3, 2011, s. 281-7.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Mygind, ND, Harutyunyan, MJ, Mathiasen, AB, Ripa, RS, Thune, JJ, Gøtze, JP, Johansen, JS, Kastrup, J & The CLARICOR Trial Group 2011, 'The influence of statin treatment on the inflammatory biomarkers YKL-40 and HsCRP in patients with stable coronary artery disease', Inflammation Research, bind 60, nr. 3, s. 281-7. https://doi.org/10.1007/s00011-010-0266-5, https://doi.org/10.1007/s00011-010-0266-5

APA

Mygind, N. D., Harutyunyan, M. J., Mathiasen, A. B., Ripa, R. S., Thune, J. J., Gøtze, J. P., Johansen, J. S., Kastrup, J., & The CLARICOR Trial Group (2011). The influence of statin treatment on the inflammatory biomarkers YKL-40 and HsCRP in patients with stable coronary artery disease. Inflammation Research, 60(3), 281-7. https://doi.org/10.1007/s00011-010-0266-5, https://doi.org/10.1007/s00011-010-0266-5

Vancouver

Mygind ND, Harutyunyan MJ, Mathiasen AB, Ripa RS, Thune JJ, Gøtze JP o.a. The influence of statin treatment on the inflammatory biomarkers YKL-40 and HsCRP in patients with stable coronary artery disease. Inflammation Research. 2011;60(3):281-7. https://doi.org/10.1007/s00011-010-0266-5, https://doi.org/10.1007/s00011-010-0266-5

Author

Mygind, Naja Dam ; Harutyunyan, Marina J ; Mathiasen, Anders Bruun ; Ripa, Rasmus Sejersten ; Thune, Jens Jacob ; Gøtze, Jens Peter ; Johansen, Julia S ; Kastrup, Jens ; The CLARICOR Trial Group. / The influence of statin treatment on the inflammatory biomarkers YKL-40 and HsCRP in patients with stable coronary artery disease. I: Inflammation Research. 2011 ; Bind 60, Nr. 3. s. 281-7.

Bibtex

@article{7ec0bebe4de44e4c84a5dbf833f3cc79,
title = "The influence of statin treatment on the inflammatory biomarkers YKL-40 and HsCRP in patients with stable coronary artery disease",
abstract = "OBJECTIVE: The inflammatory biomarker YKL-40 is elevated and associated with mortality in patients with stable coronary artery disease (CAD). The aim was to investigate the influence of statin treatment and lipid status on serum YKL-40 and Hs-CRP in patients with stable CAD. DESIGN: Serum YKL-40, HsCRP, total cholesterol, HDL-c, LDL-c and triglycerides levels were measured in 404 statin treated and in 404 matched non-statin treated patients with stable CAD. RESULTS: YKL-40 was significantly higher in non-statin treated 110 µg/l (median) compared with 65 µg/l in statin treated (p ",
author = "Mygind, {Naja Dam} and Harutyunyan, {Marina J} and Mathiasen, {Anders Bruun} and Ripa, {Rasmus Sejersten} and Thune, {Jens Jacob} and G{\o}tze, {Jens Peter} and Johansen, {Julia S} and Jens Kastrup and {The CLARICOR Trial Group}",
year = "2011",
doi = "10.1007/s00011-010-0266-5",
language = "English",
volume = "60",
pages = "281--7",
journal = "Inflammation Research",
issn = "1023-3830",
publisher = "Springer Basel AG",
number = "3",

}

RIS

TY - JOUR

T1 - The influence of statin treatment on the inflammatory biomarkers YKL-40 and HsCRP in patients with stable coronary artery disease

AU - Mygind, Naja Dam

AU - Harutyunyan, Marina J

AU - Mathiasen, Anders Bruun

AU - Ripa, Rasmus Sejersten

AU - Thune, Jens Jacob

AU - Gøtze, Jens Peter

AU - Johansen, Julia S

AU - Kastrup, Jens

AU - The CLARICOR Trial Group

PY - 2011

Y1 - 2011

N2 - OBJECTIVE: The inflammatory biomarker YKL-40 is elevated and associated with mortality in patients with stable coronary artery disease (CAD). The aim was to investigate the influence of statin treatment and lipid status on serum YKL-40 and Hs-CRP in patients with stable CAD. DESIGN: Serum YKL-40, HsCRP, total cholesterol, HDL-c, LDL-c and triglycerides levels were measured in 404 statin treated and in 404 matched non-statin treated patients with stable CAD. RESULTS: YKL-40 was significantly higher in non-statin treated 110 µg/l (median) compared with 65 µg/l in statin treated (p 

AB - OBJECTIVE: The inflammatory biomarker YKL-40 is elevated and associated with mortality in patients with stable coronary artery disease (CAD). The aim was to investigate the influence of statin treatment and lipid status on serum YKL-40 and Hs-CRP in patients with stable CAD. DESIGN: Serum YKL-40, HsCRP, total cholesterol, HDL-c, LDL-c and triglycerides levels were measured in 404 statin treated and in 404 matched non-statin treated patients with stable CAD. RESULTS: YKL-40 was significantly higher in non-statin treated 110 µg/l (median) compared with 65 µg/l in statin treated (p 

U2 - 10.1007/s00011-010-0266-5

DO - 10.1007/s00011-010-0266-5

M3 - Journal article

C2 - 20972697

VL - 60

SP - 281

EP - 287

JO - Inflammation Research

JF - Inflammation Research

SN - 1023-3830

IS - 3

ER -

ID: 32108354